Cross-Species Immunity in Malaria Vaccine Development: Two, Three, or Even Four for the Price of One?
暂无分享,去创建一个
[1] M. Mota,et al. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection. , 2007, International journal for parasitology.
[2] A. Chaudhuri,et al. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum. , 2007, Experimental parasitology.
[3] M. Deckert,et al. Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells. , 2007, The American journal of pathology.
[4] I. Mueller,et al. The risk of malarial infections and disease in Papua New Guinean children. , 2007, The American journal of tropical medicine and hygiene.
[5] I. Coppens,et al. Plasmodium yoelii Sporozoites with Simultaneous Deletion of P52 and P36 Are Completely Attenuated and Confer Sterile Immunity against Infection , 2007, Infection and Immunity.
[6] L. Rénia,et al. Vaccination against malaria with live parasites , 2006, Expert review of vaccines.
[7] J. Sattabongkot,et al. Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. , 2006, The American journal of tropical medicine and hygiene.
[8] S. Shorte,et al. Quantitative imaging of Plasmodium transmission from mosquito to mammal , 2006, Nature Medicine.
[9] C. Libert,et al. The liver stage of Plasmodium berghei inhibits host cell apoptosis , 2005, Molecular microbiology.
[10] M. Mota,et al. Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[11] L. Rénia,et al. Species-Specific Inhibition of Cerebral Malaria in Mice Coinfected with Plasmodium spp , 2005, Infection and Immunity.
[12] Ana Rodriguez,et al. Apoptotic Plasmodium-infected hepatocytes provide antigens to liver dendritic cells. , 2005, The Journal of infectious diseases.
[13] Ana Rodriguez,et al. HGF/MET signalling protects Plasmodium‐infected host cells from apoptosis , 2005, Cellular microbiology.
[14] S. Kappe,et al. Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] S. Kappe,et al. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine , 2005, Nature.
[16] John R Yates,et al. A Comprehensive Survey of the Plasmodium Life Cycle by Genomic, Transcriptomic, and Proteomic Analyses , 2005, Science.
[17] S. Kaufmann,et al. Apoptosis paves the detour path for CD8 T cell activation against intracellular bacteria , 2004, Cellular microbiology.
[18] S. Kappe,et al. Differential transcriptome profiling identifies Plasmodium genes encoding pre‐erythrocytic stage‐specific proteins , 2004, Molecular microbiology.
[19] L. Rénia,et al. Protective T Cell Immunity against Malaria Liver Stage after Vaccination with Live Sporozoites under Chloroquine Treatment 1 , 2004, The Journal of Immunology.
[20] G. Nabel. Genetic, cellular and immune approaches to disease therapy: past and future , 2004, Nature Medicine.
[21] A. Hill,et al. Malaria vaccine developments , 2004, The Lancet.
[22] M. Legorreta-Herrera,et al. Early treatment during a primary malaria infection modifies the development of cross immunity , 2004, Parasite immunology.
[23] S. Hoffman,et al. Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine , 2003, Journal of Experimental Biology.
[24] Jackie Williams,et al. Protracted Protection to Plasmodium berghei Malaria Is Linked to Functionally and Phenotypically Heterogeneous Liver Memory CD8+ T Cells1 , 2003, The Journal of Immunology.
[25] K. Day,et al. Cross-species regulation of Plasmodium parasitemia in semi-immune children from Papua New Guinea. , 2003, Trends in parasitology.
[26] Stuart M. Brown,et al. Infectivity-associated Changes in the Transcriptional Repertoire of the Malaria Parasite Sporozoite Stage* , 2002, The Journal of Biological Chemistry.
[27] Patricia De la Vega,et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. , 2002, The Journal of infectious diseases.
[28] C. Janse,et al. Comparative genomics in Plasmodium: a tool for the identification of genes and functional analysis. , 2001, Molecular and biochemical parasitology.
[29] M. Alpers,et al. Prospective risk of morbidity in relation to malaria infection in an area of high endemicity of multiple species of Plasmodium. , 2001, The American journal of tropical medicine and hygiene.
[30] M. Mota,et al. Migration of Plasmodium sporozoites through cells before infection. , 2001, Science.
[31] S. Hoffman,et al. The Complexity of Protective Immunity Against Liver-Stage Malaria1 2 , 2000, The Journal of Immunology.
[32] P. Sun,et al. The role of intrahepatic lymphocytes in mediating protective immunity induced by attenuated Plasmodium berghei sporozoites , 2000, Immunological reviews.
[33] S. Hoffman,et al. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model. , 1999, Journal of immunology.
[34] W. Collins,et al. A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum in patients previously infected with heterologous species of Plasmodium: effect on development of parasitologic and clinical immunity. , 1999, The American journal of tropical medicine and hygiene.
[35] S. Hoffman,et al. Pan DR binding sequence provides T-cell help for induction of protective antibodies against Plasmodium yoelii sporozoites. , 1999, Vaccine.
[36] G. Butcher. Cross-species Immunity in Malaria. , 1998, Parasitology today.
[37] K. Maitland,et al. Absence of malaria-specific mortality in children in an area of hyperendemic malaria. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[38] C. Newbold,et al. Plasmodium vevax and P. falciparum: Biological interactions and the possibility of cross-species immunity. , 1997, Parasitology today.
[39] C. Newbold,et al. The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[40] F J Ayala,et al. Phylogeny of the malarial genus Plasmodium, derived from rRNA gene sequences. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[41] B. Sina,et al. Plasmodium falciparum sporozoite immunization protects against Plasmodium berghei sporozoite infection. , 1993, Experimental parasitology.
[42] L. Rénia,et al. Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages. , 1993, Journal of immunology.
[43] Nirbhay Kumar,et al. Recognition of Plasmodium falciparum asexual stage antigens by antibodies in sera from people exposed to Plasmodium vivax. , 1992, The American journal of tropical medicine and hygiene.
[44] S. Hoffman,et al. A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei. , 1992, Journal of immunology.
[45] J. Sacci,et al. Mouse model for exoerythrocytic stages of Plasmodium falciparum malaria parasite. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[46] L. Rénia,et al. In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[47] I. Clark,et al. The inhibition of Plasmodium falciparum growth in vitro by sera from mice infected with malaria or treated with TNF , 1990, Parasitology.
[48] R. Sinden,et al. Survival and antigenic profile of irradiated malarial sporozoites in infected liver cells , 1990, Infection and immunity.
[49] L. Nencioni,et al. Mutants of pertussis toxin suitable for vaccine development. , 1989, Science.
[50] V. Nussenzweig,et al. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria , 1989, Nature.
[51] C. Lambros,et al. The ELISA-U: an enzyme-linked immunosorbent assay using urease as the enzyme marker for rapid detection of Plasmodium falciparum antibody in human serum. , 1988, The American journal of tropical medicine and hygiene.
[52] T. Richie. Interactions between malaria parasites infecting the same vertebrate host , 1988, Parasitology.
[53] V. Nussenzweig,et al. γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites , 1987, Nature.
[54] W. Jarra,et al. Protective immunity to malaria: studies with cloned lines of Plasmodium chabaudi and P. berghei in CBA/Ca mice. I. The effectiveness and inter‐and intra‐species specificity of immunity induced by infection , 1985, Parasite immunology.
[55] R. Nussenzweig,et al. Monoclonal antibody identifies circumsporozoite protein of Plasmodium malariae and detects a common epitope on Plasmodium brasilianum sporozoites , 1984, Infection and immunity.
[56] A. A. Mccolm,et al. Heterologous immunity in rodent malaria: comparison of the degree of cross-immunity generated by vaccination with that produced by exposure to live infection. , 1983, Annals of tropical medicine and parasitology.
[57] R. Miller,et al. Specificity of protection of man immunized against sporozoite‐induced falciparum malaria , 1973, The American journal of the medical sciences.
[58] J. Vanderberg,et al. Immunization of man against sporozite-induced falciparum malaria , 1973, The American journal of the medical sciences.
[59] J. Vanderberg,et al. Sporozoite-induced immunity in mammalian malaria. A review. , 1972, The American journal of tropical medicine and hygiene.
[60] W. Collins,et al. Immunization of monkeys against Plasmodium cynomolgi by X-irradiated sporozoites. , 1972, Nature: New biology.
[61] J. Vanderberg,et al. Specificity of Protective Immunity produced by X-irradiated Plasmodium berghei Sporozoites , 1969, Nature.
[62] J. Vanderberg,et al. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. II. Effects of radiation on sporozoites. , 1968, The Journal of parasitology.
[63] J. Vanderberg,et al. Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei , 1967, Nature.
[64] L. Bruce-Chwatt. A LONGITUDINAL SURVEY OF NATURAL MALARIA INFECTION IN A GROUP OF WEST AFRICAN ADULTS. , 1963, The West African medical journal.
[65] M. Ciucă,et al. [Effect of combined chloroquine and plasmocid therapy on various Plasmodium species inoculated for therapeutic purposes]. , 1953, Buletin stiintific. Sectiunea de stiinte medicale. Academia Republicii Populare Romine.
[66] W. B. Redmond. The Cross-Immune Relationship of Variocs Strains of Plasmodium Cathemerium and P. Relictum , 1939 .
[67] S. Kitchen,et al. Vernal Vivax Activity in Persons simultaneously inoculated with Plasmodium vivax and Plasmodium falciparum. , 1938 .
[68] S. Kitchen,et al. Recurring Clinical Activity in Infections with the McCoy Strain of Plasmodium Vivax 1 , 1937 .
[69] S. Kitchen,et al. Simultaneous Inoculation with Plasmodium vivax and Plasmodium falciparum. , 1937 .
[70] R. Carter,et al. The phylogeny of rodent malaria parasites: simultaneous analysis across three genomes. , 2007, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[71] A. Hill. Pre-erythrocytic malaria vaccines: towards greater efficacy , 2006, Nature Reviews Immunology.
[72] M. Mota,et al. Migration through host cells activates Plasmodium sporozoites for infection , 2003, Nature Medicine.
[73] C. Weijer. Another Tuskegee? , 1999, The American journal of tropical medicine and hygiene.
[74] Irwin W. Sherman,et al. Malaria : parasite biology, pathogenesis, and protection , 1998 .
[75] K. Mendis,et al. Patterns of acquired anti-malarial immunity in Sri Lanka. , 1994, Memorias do Instituto Oswaldo Cruz.
[76] F. Cox. Protective immunity between malaria parasites and piroplasms in mice. , 1970, Bulletin of the World Health Organization.
[77] G M Jeffery,et al. Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium. , 1966, Bulletin of the World Health Organization.